CeBIL Director Timo Minssen appointed to Scientific Committee of the Oslo Medicines Initiative (OMI)

Professor Timo Minssen has been appointed to the Scientific Programme Committee of the Oslo Medicines Initiative (OMI). The Oslo Medicines Initiative (OMI) has been launched by the World Health Organization (WHO)-Euro and the government of Norway to facilitate development of new collaborative modalities between the public and the private sector for improved access to effective high-cost medicines. The main responsibility of the Scientific Programme Committee is to provide advice on technical and scientific issues underpinning the programme and to help in the preparation of policy recommendations for the high-level meeting in Oslo in 2022.